A vaccine researcher at the Saint Louis University published his findings on a better substitute to the currently available anthrax vaccine, this month//.
According to peer-reviewed research published in Vaccine this new vaccine could elicit the kind of immune response doctors were looking for.
In its first human testing, the vaccine was given to 100 volunteers at four sites around the United States, said Geoffrey Gorse, M.D., a Saint Louis University researcher who was the main author of the paper.
"This type of research, five years after 9/11, continues to be very important to pursue," Gorse said. "We need a better vaccine to help protect people from anthrax infection, whether the vaccine is given before or soon after exposure to anthrax spores."
Gorse said the study was able to answer some important questions about this candidate vaccine.
"We were able to demonstrate in this study that the investigational anthrax vaccine produced an immune response that justifies further testing in larger studies," he said. "We'll be using this data to help design strategies for testing of this vaccine in the future."
Gorse indicated that the investigational vaccine, made by VaxGen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response.
The study was designed to evaluate the safety and immunogenicity of escalating doses of the new vaccine. A total of 100 healthy adults were randomized to receive either one of four different vaccine formulations, or AVA, the anthrax vaccine currently licensed for use in the United States. All vaccinations were administered intramuscularly.
Page: 1 Related medicine news :1
. Record growth of Soya-based dairy alternatives in Europe2
. Sperm stem cells could be an alternative to embryonic stem cells in future 3
. Vioxx and Celebrex, now have alternatives4
. Alternative therapy – an alternative to HRT5
. New hope for cancer victims – will vaccine cure the deadly bug6
. New vaccine helps allergy and asthma patients7
. Man against HIV – new vaccine ready for human trials8
. New vaccine helps allergy and asthma patients9
. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos10
. HIV did not arise from polio vaccine11
. Double impact vaccine